35
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Dendritic Cell-based Immunotherapy in Multiple Myeloma

Pages 2031-2038 | Published online: 05 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jianfei Qian & Qing Yi. (2012) DKK1 as a novel target for myeloma immunotherapy. OncoImmunology 1:5, pages 756-758.
Read now
Maurizio Chiriva-Internati, Everardo Cobos & W. Martin Kast. (2007) Advances in Immunotherapy of Multiple Myeloma: From the Discovery of Tumor-Associated Antigens to Clinical Trials. International Reviews of Immunology 26:3-4, pages 197-222.
Read now

Articles from other publishers (11)

Emma Verheye, Jesús Bravo Melgar, Sofie Deschoemaeker, Geert Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui & Kim De Veirman. (2022) Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions. International Journal of Molecular Sciences 23:2, pages 904.
Crossref
Qing Yi. 2013. Advances in Biology and Therapy of Multiple Myeloma. Advances in Biology and Therapy of Multiple Myeloma 25 42 .
Qing Yi, Susann Szmania, John Freeman, Jianfei Qian, Nancy A. Rosen, Sanjaya Viswamitra, Michele Cottler‐Fox, Bart Barlogie, Guido Tricot & Frits Van Rhee. (2010) Optimizing dendritic cell‐based immunotherapy in multiple myeloma: intranodal injections of idiotype‐pulsed CD40 ligand‐matured vaccines led to induction of type‐1 and cytotoxic T‐cell immune responses in patients. British Journal of Haematology 150:5, pages 554-564.
Crossref
Sungyoul Hong, Jianfei Qian, Jing Yang, Haiyan Li, Larry W. Kwak & Qing Yi. (2008) Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal while Th2 Cells Promote Tumor Growth. Cancer Research 68:20, pages 8456-8464.
Crossref
Jacalyn Rosenblatt & David Avigan. (2008) Cellular immunotherapy for multiple myeloma. Best Practice & Research Clinical Haematology 21:3, pages 559-577.
Crossref
Maud Condomines, Dirk Hose, Pierre Raynaud, Michael Hundemer, John De Vos, Marion Baudard, Thomas Moehler, Véronique Pantesco, Marion Moos, Jean-François Schved, Jean-François Rossi, Thierry Rème, Hartmut Goldschmidt & Bernard Klein. (2007) Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis. The Journal of Immunology 178:5, pages 3307-3315.
Crossref
Frits van Rhee. (2007) Idiotype Vaccination Strategies in Myeloma: How to Overcome a Dysfunctional Immune System. Clinical Cancer Research 13:5, pages 1353-1355.
Crossref
Siqing WangSungyoul HongJing YangJianfei QianXiang ZhangElizabeth ShpallLarry W. KwakQing Yi. (2006) Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. Blood 108:13, pages 4071-4077.
Crossref
Siqing WangJing YangJianfei QianMichele WezemanLarry W. KwakQing Yi. (2006) Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood 107:6, pages 2432-2439.
Crossref
H. Ludwig. 2005. Therapie innerer Krankheiten. Therapie innerer Krankheiten 1148 1162 .
Renier J. Brentjens. (2004) Novel approaches to immunotherapy for B-cell malignancies. Current Oncology Reports 6:5, pages 339-347.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.